CRISPR/Cas9 knockout cell lines

AMS Bio has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology

Drug development technology licensed

DefiniGen licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimised metabolic disease drug development

Innovative CRISPR solutions

DT showcases comprehensive CRISPR expertise in Europe

Correcting sickle cell-causing mutation

Research describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing – removing barriers for human therapeutic applications

Agreement for CRISPR engineered cell lines

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Gene editing kits launched

AMS Bio launches powerful CRISPR/Cas9 gene editing kits

Ensuring efficiency in CRISPR gene editing

Eric Rhodes reveals why CRISPR gene editing isn’t quite as easy as it looks

Cas9 enzyme variant

Reduces off-target effects in CRISPR genome editing without compromising on-target activity





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited